World Health Organization

New PeerLINC Knowledge Hub will Leverage Local Expertise and Experience to Accelerate New, More Effective TB Cures Around the World

Retrieved on:

Monday, March 25, 2024

MANILA, Australia, March 24, 2024 /PRNewswire/ -- TB Alliance's new Peer-to-Peer Learning for Innovative Cures (PeerLINC) Knowledge Hub launched today in Manila, with funding from the Australian Government through the Partnerships for a Healthy Region initiative. PeerLINC, operating in partnership between TB Alliance and the Tropical Disease Foundation, Inc. (TDF), and in close collaboration with the Department of Health, Philippines, will help countries implement best practices in the treatment of drug-resistant tuberculosis (DR-TB) to help speed the worldwide programmatic implementation of innovative, more effective treatments for the disease, starting with the World Health Organization (WHO)-recommended six-month, all-oral BPaL/M regimens, composed of the antibiotics bedaquiline (B), pretomanid (Pa), and linezolid (L), with or without moxifloxacin (M).

Key Points:

The Philippines has successfully and rapidly deployed new treatments through participation in TB Alliance's Leveraging Innovation for Faster TB Treatment ( LIFT-TB ) initiative.
"PeerLINC will make training and knowledge on new treatments available swiftly and efficiently to ensure their rapid adoption and roll out.
"Every country with drug-resistant TB can benefit from widespread implementation of the best available TB treatment.
The expert team from PeerLINC will continue to guide countries after trainings, as they work to implement the regimens.

New PeerLINC Knowledge Hub will Leverage Local Expertise and Experience to Accelerate New, More Effective TB Cures Around the World

Retrieved on:

Monday, March 25, 2024

MANILA, Australia, March 25, 2024 /PRNewswire/ -- TB Alliance's new Peer-to-Peer Learning for Innovative Cures (PeerLINC) Knowledge Hub launched today in Manila, with funding from the Australian Government through the Partnerships for a Healthy Region initiative. PeerLINC, operating in partnership between TB Alliance and the Tropical Disease Foundation, Inc. (TDF), and in close collaboration with the Department of Health, Philippines, will help countries implement best practices in the treatment of drug-resistant tuberculosis (DR-TB) to help speed the worldwide programmatic implementation of innovative, more effective treatments for the disease, starting with the World Health Organization (WHO)-recommended six-month, all-oral BPaL/M regimens, composed of the antibiotics bedaquiline (B), pretomanid (Pa), and linezolid (L), with or without moxifloxacin (M).

Key Points:

The Philippines has successfully and rapidly deployed new treatments through participation in TB Alliance's Leveraging Innovation for Faster TB Treatment ( LIFT-TB ) initiative.
"PeerLINC will make training and knowledge on new treatments available swiftly and efficiently to ensure their rapid adoption and roll out.
"Every country with drug-resistant TB can benefit from widespread implementation of the best available TB treatment.
The expert team from PeerLINC will continue to guide countries after trainings, as they work to implement the regimens.

U.S. FDA Approves OPSYNVI® (macitentan and tadalafil) as the First and Only Once-Daily Single-Tablet Combination Therapy for Patients with Pulmonary Arterial Hypertension (PAH)

Retrieved on:

Friday, March 22, 2024

RARITAN, N.J., March 22, 2024 /PRNewswire/ -- Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved OPSYNVI® – a single-tablet combination of macitentan, an endothelin receptor antagonist (ERA), and tadalafil, a phosphodiesterase 5 (PDE5) inhibitor – for the chronic treatment of adults with pulmonary arterial hypertension (PAH, World Health Organization [WHO] Group I) and WHO functional class (FC) II-III.1 OPSYNVI® may be used in patients with PAH who are treatment-naïve or who are already on an ERA, PDE5 inhibitor or both. OPSYNVI® may be used in patients who are currently treated concomitantly with stable doses of macitentan 10 mg and tadalafil 40 mg (20 mg x 2) as separate tablets.1

Key Points:

Historically, this required patients to take multiple pills because no single-tablet combination therapy targeting two or more pathways was available," said Kelly Chin, M.D., Professor of Internal Medicine and Director of the Pulmonary Hypertension Program at UT Southwestern Medical Center, and an investigator in the A DUE study.
The FDA's approval of OPSYNVI® is based on the results from the pivotal Phase 3 A DUE study , in which OPSYNVI® demonstrated greater reduction in Pulmonary Vascular Resistance (PVR) after 16 weeks versus tadalafil or macitentan monotherapy.
"People with PAH often live with the burden of taking many pills each day, which can pose challenges," said James F. List, M.D., Ph.D., Global Therapeutic Area Head, whose team oversees a portfolio of programs including Pulmonary Hypertension at Johnson & Johnson.
"We're thrilled to bring this single-tablet combination therapy to patients, as it has the potential to optimize disease management and fulfill a significant unmet need in supporting recently updated treatment guidelines that call for initial or early combination treatment."

Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote Address

Retrieved on:

Thursday, March 21, 2024

PCR, Bill, Tuberculosis, World Tuberculosis Day, Incidence, COVID-19, Sale, Death, World Health Organization, TB, Point-of-care testing, FDA

SALT LAKE CITY, March 21, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that in his keynote address at the 5th Annual MarketsandMarkets conference in London, Company CEO Dwight Egan shared an update on the new manufacturing facilities in Salt Lake City, Utah and in Ranoli, India, including announcing the grand opening of the new Utah facility next month.

Key Points:

Both Co-Dx and CoSara Diagnostics, the Company's joint venture for manufacturing in India, will be manufacturing the Co-Dx™ PCR Pro™ instrument and Co-Dx PCR test cups that run on the Company's new PCR platform*.
In-house manufacturing of the reagents as well as equipment and consumables is anticipated to play an important role as the Company prepares for commercialization of its new platform.
The estimated TB incidence rate in India alone was 2.82 million , leading to nearly 350,000 deaths for the year.
The Co-Dx PCR Pro instrument and Co-Dx COVID-19 Test are currently under review by the FDA.

TELUS Mental Health Index: Workers under 40 in the US are isolated and lonely resulting in reduced mental health and productivity

Retrieved on:

Tuesday, March 19, 2024

Health, Culture, Obesity, Trust, Social support, Mental health, Mortality, Social isolation, Organization, World Health Organization, Smoking, Housing, WHO, Workplace, Telus Health, Loneliness

Additionally, workers who don't feel valued and respected by their colleagues or supported by their workplace are twice as likely to report that their mental health adversely affects their productivity compared to workers who feel valued and respected.

Key Points:

Additionally, workers who don't feel valued and respected by their colleagues or supported by their workplace are twice as likely to report that their mental health adversely affects their productivity compared to workers who feel valued and respected.
It also impacts businesses as loneliness and social isolation negatively impact both health and workplace productivity," said Paula Allen, Global Leader, Research & Client Insights, TELUS Health.
The TELUS Mental Health Index also found:
Workers without trusted relationships are more likely to feel isolated, with 46 percent reporting feeling isolated compared to 14 percent of those with trusted relationships.
In January 2024, the mental health scores of workers in various regions were:

TELUS Mental Health Index: Employees under 40 in Canada the most isolated and lonely

Retrieved on:

Tuesday, March 19, 2024

Health, Culture, Obesity, Woman, Trust, Social support, Mental health, Bullying, Mortality, Social isolation, Organization, World Health Organization, Smoking, Housing, WHO, Workplace, Telus Health, Loneliness, Nursing

The Canadian report reveals that young Canadian workers under 40 are increasingly feeling isolated and lonely compared to their older colleagues.

Key Points:

The Canadian report reveals that young Canadian workers under 40 are increasingly feeling isolated and lonely compared to their older colleagues.
The lack of trusted relationships is a factor in loneliness, which can lead to lower mental health scores and poorer physical health.
The TELUS Mental Health Index also found:
Thirty-three per cent of workers in Canada have a high mental health risk, 45 per cent have a moderate mental health risk, and 22 per cent have a low mental health risk.
Twenty-one per cent of workers in Canada do not know if their employer provides mental health benefits or their employer does not provide mental health benefits.

TELUS Mental Health Index: Alarming isolation and loneliness levels among young workers in the UK

Retrieved on:

Tuesday, March 19, 2024

Health, Culture, Obesity, Trust, Social support, Mental health, Mortality, Social isolation, Absenteeism, Organization, World Health Organization, Smoking, Housing, WHO, Telus Health, Loneliness, Nursing

LONDON, March 19, 2024 /PRNewswire/ -- Today, TELUS Health released its TELUS Mental Health Index ("the Index") with reports that examine the mental health of employed people in the United Kingdom, the United States, Canada, Europe, Singapore, New Zealand and Australia. The UK Index highlights alarming levels of isolation and loneliness among young workers in the UK. The Index also found that workers under 40 are 80 per cent more likely to lack trusted workplace relationships compared to workers over 50.

Key Points:

The UK Index highlights alarming levels of isolation and loneliness among young workers in the UK.
"The TELUS Mental Health Index findings reflect a concerning reality, in particular for our younger workers.
It also impacts businesses as loneliness and social isolation negatively impact both health and workplace productivity," said Paula Allen, Global Leader, Research & Client Insights, TELUS Health.
The TELUS Mental Health Index also found:
Thirty-three per cent of workers in the UK have a high mental health risk, 41 per cent have a moderate mental health risk, and 26 per cent have a low mental health risk.

Safeguarding the Source: QNET Highlights the Importance of World Water Day and the Crucial Role of Home Water Filters

Retrieved on:

Wednesday, March 13, 2024

UNSDG, World Health Organization, Health, Face, Shoulder, Public, QNET, Bacteria, Virus, Hope, Water resources, World Water Day, Reputation, Fresh water, Water, Drinking water, Bottled water

In the face of mounting global water crises, home water filters emerge as a beacon of hope, offering a tangible solution to ensure the purity of our most precious resource.

Key Points:

In the face of mounting global water crises, home water filters emerge as a beacon of hope, offering a tangible solution to ensure the purity of our most precious resource.
The World Health Organization warns of the grave health risks posed by contaminated water sources, underscoring the urgency of securing a safe water supply .
Investing in home water filters isn't just about personal health; it's a collective commitment to safeguarding public health and well-being on a global scale.
Kuna also stated that "Investing in home water filters isn't merely a personal choice; it's a powerful statement in support of global water conservation efforts.

Google Cloud Announces New Generative AI Advancements for Healthcare and Life Science Organizations

Retrieved on:

Tuesday, March 12, 2024

ORLANDO, Fla., March 12, 2024 /PRNewswire/ -- Today at HIMSS24, Google Cloud announced several new solutions to help healthcare and life sciences organizations enable interoperability, build a better data foundation for their businesses, and deploy generative AI (gen AI) tools to improve patient outcomes.

Key Points:

These search and question-answering capabilities now integrate with MedLM , Healthcare Data Engine (HDE) and Cloud Healthcare FHIR APIs , making it easier for healthcare and life science organizations to build the data analytics and AI solutions needed for next era health systems.
Configurable cloud APIs: Healthcare application developers can integrate the medically-tuned search directly into the clinician workflow tools using configurable cloud APIs.
"Not all generative AI is created equal, and in healthcare, the stakes are particularly high," said Aashima Gupta, global director for Healthcare Strategy & Solutions, Google Cloud.
For more information on these technology advancements for healthcare and life sciences, stop by the Google booth #2512 at HIMSS24 , and please contact your Google Cloud sales team to learn more.

World Vaccine Congress Draws Leaders from Government, Science and Industry

Retrieved on:

Monday, March 11, 2024

Convention center, Bee, Washington Convention Center, Congress, Walter, Global health, Mayo Clinic, Food and Drug Administration, Cancer, International, Science Advisory Board, World Health Organization, Immunization, Vaccination, Bangladesh Technical Education Board, Vaccine, Food, Pharmaceutical industry

WASHINGTON, March 11, 2024 /PRNewswire/ -- The world's top experts and policymakers, including government leaders, renown researchers and company executives driving vaccine development, will gather to discuss the latest progress in vaccines — from efforts to inoculate bees to a discussion of pathogens that could cause the next pandemic — at the World Vaccine Congress April 1-4.

Key Points:

"We have assembled the world's foremost experts and policymakers in the field of vaccination for the 2024 World Vaccine Congress," said Dr. Gregory A. Poland, Director of Mayo Vaccine Research Group, Mayo Clinic and a member of the Science Advisory Board.
"This event represents an unparalleled opportunity for collaboration and innovation and promises to drive meaningful progress in global health.
It is a unique and massive forum for discovery and access to leaders across the field."
In-depth sessions also cover vaccine supply and logistics, veterinary vaccines, emerging diseases, and vaccine delivery.